Global Insomnia Treatment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Treatment Type;

Drug - Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonist, Melatonin Antagonist, and Other Treatment, Devices.

By Distribution Channel;

Hospital Pharmacies, Retail Pharmacies and Drug Stores, and Online Pharmacies.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn157215978 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Insomnia Treatment Market (USD Million), 2021 - 2031

In the year 2024, the Global Insomnia Treatment Market was valued at USD 4,112.43 million. The size of this market is expected to increase to USD 5,864.20 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.2%.

The global insomnia treatment market is experiencing significant growth due to the increasing prevalence of sleep disorders and heightened awareness about sleep health. Insomnia, characterized by difficulties in falling asleep, staying asleep, or experiencing non-restorative sleep, affects millions of people worldwide. This widespread issue drives demand for various treatment options, including prescription medications, over-the-counter remedies, and behavioral therapies. As lifestyles become more hectic and stress levels rise, the need for effective solutions to manage and alleviate insomnia is becoming more pronounced, prompting a growing focus on innovative treatments and interventions.

Advancements in sleep medicine, coupled with increasing investments in research and development, are contributing to the expansion of the insomnia treatment market. Pharmaceutical companies and healthcare providers are exploring new drug formulations and therapeutic approaches, while technological innovations such as sleep-tracking devices and mobile health applications offer additional support for managing sleep disorders. The market is also influenced by rising public awareness of the impact of sleep on overall health, leading to greater emphasis on both preventive measures and treatment options. As the understanding of sleep disorders evolves, the insomnia treatment market is poised for continued growth, driven by the demand for effective and personalized solutions to address this common and often debilitating condition.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Treatment Type
    2. Market Snapshot, By Distribution Channel
    3. Market Snapshot, By Region
  4. Global Insomnia Treatment Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Growing Demand for Non-Pharmacological Therapies

        2. Expansion of Telemedicine and Digital Health Solutions

        3. Lifestyle Changes and Increased Stress Levels

      2. Restraints
        1. Regulatory and Approval Challenges

        2. High Costs of Advanced Treatments

        3. Limited Access to Behavioral Therapies

      3. Opportunities
        1. Growth in Digital Health and Mobile Applications

        2. Innovation in Drug Development and Formulations

        3. Expansion of Non-Pharmacological Treatment Options

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Insomnia Treatment Market, By Treatment Type, 2021 - 2031 (USD Million)
      1. Drug
      2. Benzodiazepines
      3. Nonbenzodiazepines
      4. Antidepressants
      5. Orexin Antagonist
      6. Melatonin Antagonist
      7. Devices
    2. Global Insomnia Treatment Market, By Distribution Channel, 2021 - 2031 (USD Million)
      1. Hospital Pharmacies
      2. Retail Pharmacies and Drug Stores
      3. Online Pharmacies
    3. Global Insomnia Treatment Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Pfizer Inc.
      2. Sanofi S.A.
      3. Mylan N.V.
      4. Takeda Pharmaceutical Company Ltd.
      5. Merck & Co
  7. Analyst Views
  8. Future Outlook of the Market